Saga Metals Corp-Logo-01-Dark Version.png
Saga Metals Corp. Announces Closing of Initial Public Offering and Other Corporate Updates
September 23, 2024 14:36 ET | Saga Metals Corp.
Saga Metals Corp. is pleased to announce the successful closing of its initial public offering for gross proceeds of $1,758,500 and listing on the TSXV.
Synthetic Sapphire Market
Synthetic Sapphire Market Report 2024: Competitive Landscape and Company Profiles for Goodfellow, Cooksongold, Alkor Technologies, Microlap Technologies and Beach Gem & Jewelry Co.
September 23, 2024 07:52 ET | Research and Markets
Dublin, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The "Synthetic Sapphire Market Report 2024" has been added to ResearchAndMarkets.com's offering. The synthetic sapphire market size has grown strongly...
Synthetic Quartz Market
Synthetic Quartz Industry Business Report 2024: Advanced Semiconductor Manufacturing Expands Market Opportunities - Global Forecast to 2030
September 19, 2024 10:18 ET | Research and Markets
Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "Synthetic Quartz - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Synthetic...
apogee_gc_logo.jpg
Apogee Minerals Completes Geophysical Work at the Pine Channel and Shasko Bay Projects, Saskatchewan
September 19, 2024 08:00 ET | Apogee Minerals Ltd.
Vancouver, British Columbia, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Apogee Minerals Ltd. (“Apogee” or the “Company”) (TSXV: APMI) is pleased to announce that the Company has completed field programs...
22157.jpg
Critical Minerals in Defense Thematic Intelligence Research 2024
September 17, 2024 09:42 ET | Research and Markets
Dublin, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The "Thematic Intelligence: Critical Minerals in Defense (2024)" report has been added to ResearchAndMarkets.com's offering.This report explores the use,...
ApogeeLogo.png
Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit
September 12, 2024 07:00 ET | Apogee Therapeutics
SAN FRANCISCO and WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with potential for...
N27481-6931-Edit 1
Sanborn Map Company Inc. Enhances Geophysical Survey Capabilities with Advanced Airborne Technology
September 04, 2024 07:24 ET | The Sanborn Map Company
The Sanborn Map Company has advanced its geophysical survey and mapping services by equipping its fleet with state-of-the-art geophysical survey technology
CMN_Masterbrand_EN_RGB.png
Le Musée canadien de la nature offre des ateliers scolaires virtuels gratuits
August 27, 2024 15:30 ET | Musée canadien de la nature
OTTAWA, 27 août 2024 (GLOBE NEWSWIRE) -- Les enseignants de tout le Canada peuvent désormais accéder à des ateliers virtuels gratuits au Musée canadien de la nature. Lancés en mars 2021, ces...
CMN_Masterbrand_EN_RGB.png
Canadian Museum of Nature now offering free virtual school workshops
August 27, 2024 15:30 ET | Canadian Museum of Nature
Free online nature-themed workshops now offered by the Canadian Museum of Nature for teachers across Canada
ApogeeLogo.png
Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG990, its Novel Half-Life Extended OX40L Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases
August 19, 2024 07:00 ET | Apogee Therapeutics, LLC
Interim safety and pharmacokinetic data from Phase 1 healthy volunteers trial anticipated in 2025 Initiation of the first clinical trial of APG777 and APG990 combination expected to commence in...